Imax CORP Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
NYSE
IMAX
Imax CORPIMAX Corp director Darren Throop reported transactions involving common shares and restricted share units on June 11, 2026.
NYSE
IMAX
Imax CORPIMAX Corp Director Michael MacMillan reported transactions involving common shares and restricted share units on June 11, 2026.
NYSE
IMAX
Imax CORPIMAX Corp director Dana R. Settle has reported the acquisition of 3,390 common shares through the vesting of restricted share units.
NYSE
IMAX
Imax CORPIMAX Corporation Director Jennifer L. Wong reported a transaction involving the acquisition of 3,390 common shares upon the vesting of restricted share units.
NYSE
IMAX
Imax CORPIMAX Corporation Director Steve Pamon reported transactions involving restricted share units converting to common shares.
NYSE
IMAX
Imax CORPIMAX Corporation Director Gail Berman acquired 3,390 common shares through the vesting of restricted share units.
NYSE
IMAX
Imax CORPIMAX Corporation director David W. Leebron has reported the acquisition of 3,390 common shares through the vesting of restricted share units.
NYSE
IMAX
Imax CORPIMAX Corp reports a Form 4 filing detailing a transaction by Director Kevin Douglas, who acquired 3,390 shares of common stock.
NYSE
IMAX
Imax CORPIMAX CEO Richard Gelfond exercised stock options and sold the resulting common shares under a pre-arranged 10b5-1 trading plan.
NYSE
IMAX
Imax CORPIMAX CEO Richard Gelfond exercised and sold 120,132 shares of common stock under a pre-arranged 10b5-1 trading plan.
NYSE
IMAX
Imax CORPIMAX CEO Richard Gelfond reported transactions involving company stock, including the exercise of stock options and the sale of common shares.
NYSE
IMAX
Imax CORPIMAX CEO Richard Gelfond executed transactions involving the purchase and sale of company shares under a pre-arranged 10b5-1 trading plan.
NYSE
IMAX
Imax CORPIMAX Corporation's CEO of IMAX China Holding, Inc., Daniel Manwaring, has filed an amendment to a previous Form 4, correcting details regarding the withholding of shares for tax purposes and updating his beneficial ownership.
NYSE
IMAX
Imax CORPIMAX Director and 10% owner Kevin Douglas, along with related entities, plans to sell 568,000 shares of common stock for approximately $21.5 million on March 16, 2026, under a 10b5-1 plan.
NYSE
IMAX
Imax CORPIMAX CEO Richard L. Gelfond exercised stock options and immediately sold the resulting common shares as part of a pre-arranged 10b5-1 trading plan.
NYSE
IMAX
Imax CORPIMAX CEO Richard L. Gelfond reported the conversion of restricted share units into common shares and subsequent tax-related share disposals, resulting in a net increase in his direct common share holdings to 635,940.
NYSE
IMAX
Imax CORPIMAX Global Theatres President Mark Welton sold 25,000 common shares for $39.28 each, as part of a pre-arranged 10b5-1 trading plan.
NYSE
IMAX
Imax CORPIMAX Chief Legal Officer Robert D. Lister gifted 2,000 common shares to a donor-advised fund, citing upcoming changes in tax regulations for charitable donations.
NYSE
IMAX
Imax CORPIMAX Chief Financial Officer Natasha Fernandes exercised stock options and subsequently sold an equal number of common shares on November 24, 2025.
NYSE
IMAX
Imax CORPIMAX CEO Richard L. Gelfond gifted 40,000 common shares to a donor-advised fund, citing upcoming changes in tax regulations.
NYSE
IMAX
Imax CORPIMAX Global Theatres President Mark Welton exercised stock options and subsequently sold the acquired common shares on November 10, 2025.
NYSE
IMAX
Imax CORPIMAX Chief Commercial Officer Giovanni M. Dolci exercised stock options and subsequently sold the acquired common shares on November 10, 2025, as part of a pre-arranged 10b5-1 plan.
NYSE
IMAX
Imax CORPIMAX Corporation's CTO and EVP, Pablo Calamera, sold 20,586 common shares for approximately $704,500 on November 10, 2025.
NYSE
IMAX
Imax CORPIMAX's Chief Legal Officer, Robert D. Lister, exercised stock options and subsequently sold 50,143 common shares on November 7, 2025, under a 10b5-1 plan.
NYSE
IMAX
Imax CORPIMAX Chief Legal Officer Robert D. Lister sold 20,000 common shares for $32.80 each, executing a pre-arranged 10b5-1 trading plan.
NYSE
IMAX
Imax CORPIMAX Deputy GC Kenneth Weissman exercised stock options and subsequently sold a portion of his common shares.
NYSE
IMAX
Imax CORPIMAX Chief Commercial Officer Giovanni M. Dolci sold 6,500 common shares at $24.9951 per share under a Rule 10b5-1 plan.
NYSE
IMAX
Imax CORPIMAX Corp. Director Michael MacMillan converted 4,558 restricted share units into common shares and subsequently disposed of 2,483 shares for tax withholding, increasing his direct beneficial ownership to 38,028 common shares.
NYSE
IMAX
Imax CORPIMAX Corporation Director Steve Pamon has increased his direct beneficial ownership of common shares to 32,125 after the vesting and conversion of 4,558 restricted share units on June 12, 2025.
NYSE
IMAX
Imax CORPIMAX Corporation Director Dana R. Settle has increased her direct beneficial ownership of company common shares to 65,700 after the vesting and conversion of 4,558 restricted share units on June 12, 2025.